Nationwide trends in physician consultation and surgical management for pelvic organ prolapse in Japan, 2014 to 2024: a health insurance claims database analysis. [PDF]
Nariai M +5 more
europepmc +1 more source
Cervical pessary versus vaginal progesterone in women with a multiple pregnancy and a short cervix: A randomised controlled trial. [PDF]
van Dijk CE +19 more
europepmc +1 more source
Discontinuation of pessary therapy within 24 months: can it be predicted?
Introduction: Pelvic organ prolapse is a distressing condition affecting women. Pessary therapy is a conservative and effective treatment option. However, 20–60% of women discontinue pessary treatment within 24 months.
Elting, L. M. +3 more
core
Combined vaginal progesterone and cervical Pessary effect on preterm birth in Singleton pregnancies with short cervix: a retrospective cohort study. [PDF]
Eshraghi N +6 more
europepmc +1 more source
Comments on: A new screening of preterm birth in gestation with short cervix after pessary plus progesterone. [PDF]
Unfer V.
europepmc +1 more source
Spectrum of Cervical Insufficiency: Management Strategies from Asymptomatic Shortening to Emergent Membrane Prolapse. [PDF]
Baroutis D +9 more
europepmc +1 more source
Genitourinary syndrome of menopause. [PDF]
Burgin J, Manning L, Kearley-Shiers K.
europepmc +1 more source
Prolaps zdjeličnih organa (POP) predstavlja čest zdravstveni problem kod žena, uzrokujući spuštanje zdjeličnih organa u rodnicu zbog oslabljene potpore zdjeličnog dna.
Vranjković, Stjepan
core

